Trial Details
RECRUITINGBasic Information
| Clinical ID | c1781 |
|---|---|
| Identifier | NCT06430801 |
| Trial Title | A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: IV Tulisokibart|DRUG: SC Tulisokibart|OTHER: IV Placebo|OTHER: SC Placebo |
Participant Information
| Sponsor | Merck Sharp & Dohme LLC |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2024-06-05 |
|---|---|
| Primary Completion Date | 2028-10-30 |
| Completion Date | 2029-11-12 |